Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

This study is testing whether an artificial intelligence (AI) tool can better predict which bladder cancer patients are most at risk of their cancer returning or getting worse, helping doctors make more personalised treatment decisions. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with intermediate- or high-risk non-muscle invasive bladder cancer (cancer that has not grown into the deep muscle of the bladder wall) - You have received treatment directly into the bladder (BCG, mitomycin C, or gemcitabine/docetaxel) within the past 6 months - You speak English or Spanish - You are willing to provide informed consent **You may NOT be eligible if...** - Your cancer has invaded the muscle wall of the bladder (stage T2 or higher) - There was not enough tissue available from your bladder surgery for testing - You are receiving systemic (whole-body) chemotherapy - You are unable to read or write in English or Spanish Talk to your doctor to see if this trial is right for you.